Join to View Full Profile
2207 S Clear Creek RdSte 302Killeen, TX 76549
Phone+1 254-526-5353
Fax+1 254-554-5298
Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 1976 - 1978
Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)Residency, Internal Medicine, 1975 - 1976- Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)Residency, Internal Medicine, 1973 - 1974
Madurai Medical CollegeClass of 1971
Certifications & Licensure
TX State Medical License 1983 - 2024
MO State Medical License 2019 - 2020
NY State Medical License 1977 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 72 citationsCharacterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH.Davide Povero, Hirokazu Yamashita, Wenhua Ren, Mani Subramanian, Robert P. Myers
Hepatology Communications. 2020-07-03 - 190 citationsIdentification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes.Sergio Borgia, Charlotte Hedskog, Bandita Parhy, Robert H. Hyland, Luisa M. Stamm
The Journal of Infectious Diseases. 2018-10-20 - 2 citationsDraft Genome Sequence of the Bacterium Pseudomonas putida CBB5, Which Can Utilize Caffeine as a Sole Carbon and Nitrogen Source.Erik M. Quandt, Ryan M. Summers, Mani Subramanian, Jeffrey E. Barrick
Genome Announcements. 2015-06-25
Press Mentions
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical DevelopmentOctober 29th, 2019
Grant Support
- Novel therapy for alcoholic liver disease-associated hepatorenal syndromeMITOPOWER LLC2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
